Covalent Functionalized Self-Assembled Lipo-Polymerosome Bearing Amphotericin B for Better Management of Leishmaniasis and Its Toxicity Evaluation-Reference-Cited by-同舟云学术

Covalent Functionalized Self-Assembled Lipo-Polymerosome Bearing Amphotericin B for Better Management of Leishmaniasis and Its Toxicity Evaluation

Published:2014-02-19 Issue:3 Volume:11 Page:951-963
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Gupta Pramod K.¹,Jaiswal Anil K.¹,Kumar Vivek¹,Verma Ashwni¹,Dwivedi Pankaj¹,Dube Anuradha¹,Mishra Prabhat R.¹

Affiliation:

1. Pharmaceutics Division and ‡Parasitology Division, Council of Scientific and Industrial Research-Central Drug Research Institute, B 10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow, India 226031

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp400603t

Reference48 articles.

1. Anti-leishmanial activity of a new formulation of amphotericin B

2. Interactions of the drug amphotericin B with phospholipid membranes containing or not ergosterol: new insight into the role of ergosterol

3. Toward Understanding of Toxic Side Effects of a Polyene Antibiotic Amphotericin B: Fluorescence Spectroscopy Reveals Widespread Formation of the Specific Supramolecular Structures of the Drug

4. Study of the toxicity of a new lipid complex formulation of amphotericin B

5. Quaternary ammonium palmitoyl glycol chitosan—a new polysoap for drug delivery

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications;Life;2023-03-29

2. Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review;Frontiers in Bioengineering and Biotechnology;2022-12-14

3. Orally Administered Amphotericin B Nanoformulations: Physical Properties of Nanoparticle Carriers on Bioavailability and Clinical Relevance;Pharmaceutics;2022-08-30

4. The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis;Acta Parasitologica;2022-07-20

5. Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis – A review;Biomedicine & Pharmacotherapy;2021-09